171 related articles for article (PubMed ID: 16252416)
1. Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis.
Jaber BL; Madias NE
N Engl J Med; 2005 Oct; 353(17):1858-60; author reply 1858-60. PubMed ID: 16252416
[No Abstract] [Full Text] [Related]
2. Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis.
Robinson JG
N Engl J Med; 2005 Oct; 353(17):1858-60; author reply 1858-60. PubMed ID: 16252415
[No Abstract] [Full Text] [Related]
3. Charting new territory by simulated modeling of a clinical trial.
Tuttle KR
Clin J Am Soc Nephrol; 2010 May; 5(5):750-2. PubMed ID: 20360306
[No Abstract] [Full Text] [Related]
4. Statins for patients with type 2 diabetes.
Pimpinella G; Bertini Malgarini R; Martini N
Lancet; 2004 Nov 27-Dec 3; 364(9449):1933; author reply 1933. PubMed ID: 15566999
[No Abstract] [Full Text] [Related]
5. Statins for patients with type 2 diabetes.
Auer J; Berent R; Weber T; Eber B
Lancet; 2004 Nov 27-Dec 3; 364(9449):1933-4. PubMed ID: 15566997
[No Abstract] [Full Text] [Related]
6. Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis.
Langer A
N Engl J Med; 2005 Oct; 353(17):1858-60; author reply 1858-60. PubMed ID: 16251546
[No Abstract] [Full Text] [Related]
7. Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis?
Kwan BC; Beddhu S; Kronenberg F; Cheung AK
Nat Clin Pract Nephrol; 2006 Feb; 2(2):76-7. PubMed ID: 16932397
[No Abstract] [Full Text] [Related]
8. Statin treatment of patients with diabetes.
Eisenbarth GS
Curr Diab Rep; 2005 Apr; 5(2):83. PubMed ID: 15794908
[No Abstract] [Full Text] [Related]
9. Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D study.
Hoffmann MM; März W; Genser B; Drechsler C; Wanner C
Atherosclerosis; 2011 Dec; 219(2):659-62. PubMed ID: 21871624
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
Wanner C; Krane V; März W; Olschewski M; Mann JF; Ruf G; Ritz E;
N Engl J Med; 2005 Jul; 353(3):238-48. PubMed ID: 16034009
[TBL] [Abstract][Full Text] [Related]
11. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Mackness MI; Charlton-Menys V; Fuller JH;
Lancet; 2004 Aug 21-27; 364(9435):685-96. PubMed ID: 15325833
[TBL] [Abstract][Full Text] [Related]
12. ASCOT-LLA: questions about the benefits of atorvastatin.
Ravnskov U
Lancet; 2003 Jun; 361(9373):1986; author reply 1986-7. PubMed ID: 12801761
[No Abstract] [Full Text] [Related]
13. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): response to Server et al.
Tseng KH
Diabetes Care; 2005 Oct; 28(10):2595; author reply 2595-6. PubMed ID: 16186315
[No Abstract] [Full Text] [Related]
14. Statins in rheumatoid arthritis--two birds with one stone?
Klareskog L; Hamsten A
Lancet; 2004 Jun; 363(9426):2011-2. PubMed ID: 15207947
[No Abstract] [Full Text] [Related]
15. Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis.
Krane V; Heinrich F; Meesmann M; Olschewski M; Lilienthal J; Angermann C; Störk S; Bauersachs J; Wanner C; Frantz S;
Clin J Am Soc Nephrol; 2009 Feb; 4(2):394-400. PubMed ID: 19158371
[TBL] [Abstract][Full Text] [Related]
16. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
Gangaidzo IT
Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
[No Abstract] [Full Text] [Related]
17. Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Thomason MJ; Fuller JH;
Diabetologia; 2005 Dec; 48(12):2482-5. PubMed ID: 16284747
[TBL] [Abstract][Full Text] [Related]
18. Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes.
Chan KE; Thadhani R; Lazarus JM; Hakim RM
Clin J Am Soc Nephrol; 2010 May; 5(5):856-66. PubMed ID: 20338963
[TBL] [Abstract][Full Text] [Related]
19. Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Callahan A; Amarenco P; Goldstein LB; Sillesen H; Messig M; Samsa GP; Altafullah I; Ledbetter LY; MacLeod MJ; Scott R; Hennerici M; Zivin JA; Welch KM;
Arch Neurol; 2011 Oct; 68(10):1245-51. PubMed ID: 21670382
[TBL] [Abstract][Full Text] [Related]
20. From CARDS to AURORA: one disease, two responses.
Escobar C; Barrios V; Echarri R
Hellenic J Cardiol; 2010; 51(3):281. PubMed ID: 20515865
[No Abstract] [Full Text] [Related]
[Next] [New Search]
